1. Home
  2. LRE vs RGNT Comparison

LRE vs RGNT Comparison

Compare LRE & RGNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lead Real Estate Co. Ltd

LRE

Lead Real Estate Co. Ltd

N/A

Current Price

$1.10

Market Cap

17.9M

Sector

N/A

ML Signal

N/A

Logo Regentis Biomaterials Ltd. Ordinary Shares

RGNT

Regentis Biomaterials Ltd. Ordinary Shares

N/A

Current Price

$1.18

Market Cap

14.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LRE
RGNT
Founded
2001
2004
Country
Japan
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.9M
14.3M
IPO Year
2022
2022

Fundamental Metrics

Financial Performance
Metric
LRE
RGNT
Price
$1.10
$1.18
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
7.7K
★ 28.5K
Earning Date
07-30-2015
09-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$3.16
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.00
$1.23
52 Week High
$1.83
$15.50

Technical Indicators

Market Signals
Indicator
LRE
RGNT
Relative Strength Index (RSI) 47.85 28.92
Support Level $1.04 N/A
Resistance Level $1.15 $2.48
Average True Range (ATR) 0.04 0.11
MACD 0.01 -0.00
Stochastic Oscillator 58.33 0.00

Price Performance

Historical Comparison
LRE
RGNT

About LRE Lead Real Estate Co. Ltd

Lead Real Estate Co Ltd operates as a developer of luxury residential properties, including single-family homes and condominiums, across Tokyo, Kanagawa Prefecture, and Sapporo. The company also operates hotels in Tokyo and leases apartment units to individual customers in Japan and Dallas, Texas. Its revenue is predominantly generated from developing and selling single-family homes and condominiums, hotel operations, and residential leasing. The company's sole operating segment is real estate sales. Geographically, it derives revenue from Japan.

About RGNT Regentis Biomaterials Ltd. Ordinary Shares

Regentis Biomaterials Ltd is a regenerative medicine company dedicated to developing tissue repair solutions that restore health and enhance the quality of life of patients. It is focused on orthopedic treatments using its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue (inflamed cartilage and bone tissue). Gelrin is a hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen (a biologically inactivated protein that normally has a role in blood clotting). Its product is GelrinC, a cell-free, off-the-shelf hydrogel that is cured into an implant in the knee for the treatment of painful injuries to articular knee cartilage.

Share on Social Networks: